How much does a Workplace Drug Testing Service cost to buy?

A typical Workplace Drug Testing Service sells for 3x to 5x annual revenue. With average revenue of $750K, expect to pay $2.3M to $3.8M.

How much does it cost to start a Workplace Drug Testing Service?

Startup costs range from $30K to $175K depending on location, equipment, and scale.

Service

Workplace Drug Testing Service

Q: What are the profit margins for a Workplace Drug Testing Service?

The average profit margin for a Workplace Drug Testing Service is around 23%. Key costs include collectors, lab fees, rent, software, insurance, and sales. Grand View Research estimated the U.S. drug screening market at about $2.54B in 2023, while the U.S. drug-of-abuse testing services market was roughly $992.6M in 2024, showing how large the employer and safety-testing niche already is.

Compliance testing for employers who cannot afford bad hires or failed audits

Workplace drug testing companies provide pre-employment, random, post-accident, and DOT-compliant testing for employers. Demand is driven less by consumer taste and more by insurance, safety, regulation, and HR policy — which makes it a quietly durable boring business.

Share on X Share on LinkedIn

Avg Revenue

$750K

Profit Margin

23%

Acquisition Multiple

3x - 5x

Startup Cost

$30K - $175K

Difficulty

4/5

How It Works

The operator contracts with employers, staffing firms, schools, and transportation fleets to run scheduled and on-demand tests. Revenue comes from urine, saliva, hair, and instant tests, plus consortium management, mobile collections, and occupational health add-ons. The best firms win on turnaround speed, chain-of-custody reliability, and account retention.

Revenue Range

Low End

$200K

Typical

$750K

High End

$2.0M

Pros

+Compliance-driven recurring demand from employer accounts
+High trust and operational discipline create retention
+Mobile collections and after-hours testing support premium pricing
+Cross-sells naturally into background screening and occupational health

Cons

-Documentation errors can create liability
-Account concentration can hurt if one big employer leaves
-Some growth depends on local labor-market conditions
-Clinical compliance and collector training matter

Best For

Operators who like B2B compliance services, account management, and process discipline

Operating Costs

Key costs include collectors, lab fees, rent, software, insurance, and sales. Grand View Research estimated the U.S. drug screening market at about $2.54B in 2023, while the U.S. drug-of-abuse testing services market was roughly $992.6M in 2024, showing how large the employer and safety-testing niche already is.